Research Tracker›Biomarker Atlas›ME/CFS›Heart rate variability (RMSSD)

Heart rate variability (RMSSD) in ME/CFS

In ME/CFS (ME/CFS, CFS), published studies report lower levels of Heart rate variability (RMSSD), also described as Parasympathetic tone, than in healthy controls. Clinically, it has been associated with dysautonomia, orthostatic intolerance. The evidence summarised here comes from Nelson et al. 2019 and reflects averages across cohorts rather than any single patient's result.

↓ ReducedAutonomic

Summary

Direction in ME/CFS↓ Reduced — lower than in the comparison group
CategoryAutonomic
Also described asParasympathetic tone
Compared againstHC (healthy controls)
Associated symptomsDysautonomia, orthostatic intolerance
Test typeClinical or physiological test
SourceNelson et al. 2019 — doi:10.1186/s12967-019-02100-4
Condition atlasME/CFS Biomarker Atlas

Other conditions where Heart rate variability (HRV) is reported

See the cross-condition hub: Heart rate variability (HRV) across conditions.

Related Autonomic markers in ME/CFS

Full list: ME/CFS Biomarker Atlas.

Frequently asked questions

Is Heart rate variability (RMSSD) high or low in ME/CFS?

Reduced. Studies summarised in the OSMF atlas report lower Heart rate variability (RMSSD) in ME/CFS than in healthy controls. Source: Nelson et al. 2019.

What symptoms is Heart rate variability (RMSSD) associated with in ME/CFS?

The cited literature associates this marker with Dysautonomia, orthostatic intolerance. These are population-level associations and do not mean the marker causes the symptoms.

Which test measures Heart rate variability (RMSSD)?

It is measured as a clinical or physiological test. Many of the cited studies used research-grade assays, so clinical availability may vary.

Is one abnormal Heart rate variability (RMSSD) result diagnostic of ME/CFS?

No. No single biomarker is diagnostic of ME/CFS. Heart rate variability (RMSSD) findings come from group comparisons, overlap considerably between patients and controls, and vary with study design, timing and comparison group. A result should be interpreted by a clinician alongside symptoms, history and other tests.

Is Heart rate variability (RMSSD) specific to ME/CFS?

No. The same marker is also reported in Gulf War Illness, Lyme Disease, ME/CFS, PACVS in this atlas, so it reflects shared biology (for example inflammation or vascular stress) rather than a condition-specific signature.

Cite this page

Open Source Medicine Foundation. (2026). Heart rate variability (RMSSD) in ME/CFS: direction, evidence and what it means. OSMF Research Tracker. Retrieved October 7, 2026, from https://research.opensourcemed.info/biomarkers/me-cfs/heart-rate-variability-rmssd.html
Get OSMF research updates. New biomarker, trial and treatment evidence summaries by email.
Subscribe on Substack

Last reviewed: 2026-06-29 · Page generated from me-cfs.json · Browse: ME/CFS atlas · Biomarker Index · All marker pages

Disclaimer: This page is an educational synthesis of published, peer-reviewed research and is not medical advice. Biomarker findings vary across studies with case definitions, comparison groups, timing and assay methods. Direction of change reflects the predominant finding in the cited source and does not establish a diagnostic threshold. Discuss any test result with a qualified clinician.